¡¾ÕªÒª¡¿ Ä¿µÄ Ñо¿Ñ¨Î»×¢Éä¶ÔÖÎÁÆÄÔ×äÖкó¼ÙÐÔÇòÂé±ÔËùÖµÄÍÌÑÊÀ§ÄѵÄЧ¹û¡£ ·½·¨ ²ÉȡѨλעÉäÖÎÁÆ×éºÍµ¥´¿Õë´Ì¶ÔÕÕ×飬½«»¼ÕßËæ»ú·ÖΪÖÎÁÆ×é30Àý£¬¶ÔÕÕ×é30Àý£¬ÒÔÍÌÑʹ¦Äܵı仯ΪÖ÷Òª¹Û²ìÖ¸±ê£¬½øÐÐÖÎÁÆÇ°ºóÁÆЧµÄ¹Û²ìÓëͳ¼Æѧ´¦Àí¡£ ½á¹û ÖÎÁÆ×é×ÜÓÐЧÂÊΪ93.33%£»¶ÔÕÕ×é×ÜÓÐЧÂÊΪ70.00%£¬Á½×éÖ®¼äµÄ²îÒìÓÐͳ¼ÆѧÒâÒ壨p<0.05£©¡£ ½áÂÛ Ñ¨Î»×¢ÉäÖÎÁÆ×äÖкóÍÌÑÊÀ§ÄÑÓÐÏÔÖøÐÔÁÆЧ¡£ª¥
¡¡¡¡¡¾¹Ø¼ü´Ê¡¿ ¼ÙÐÔÇòÂé±Ô£»ÍÌÑÊÀ§ÄÑ£»ÄÔ×äÖЪ¤ª¤
¡¡¡¡
¡¡¡¡to observe the curative effect of injectio ad acumen treatment of 30 cases with supranuclear paralysis
¡¡¡¡
¡¡¡¡liu wei,yang xiao-lin£¬zhang xing-hui.
¡¡¡¡the second hospital of tianjin medical university, 300211
¡¡¡¡ª¥
¡¡¡¡¡¾abstract¡¿ objective to observe the curative effect of injectio ad acumen to 30 supranuclear paralysis cases with dysphagia.methods cases were randomly divided into injectio ad acumen and single acupuncture treatment group, each of them has 30 cases respectively. improvement of dysphagia was the main obserable index, and the data of pre-and post-treatment was being statistical treatment.results the effective rate of injectio ad acumen and single acupuncture treatment group was 93.33% and 70.00% respetively, so there has significant stastical difference between the two groups(p<0.01). conclusion injectio ad acumen treatment has significant effect in patients with dysphagia.ª¥
¡¡¡¡¡¾key words¡¿ supranuclear paralysis; dysphagia; stroke
¡¡¡¡
¡¡¡¡ÄÔ×äÖкó¼ÙÐÔÇòÂé±ÔÖÂÍÌÑÊÀ§ÄÑÓëËæÖ®¶øÀ´µÄÎóÎüÊdz£¼ûµÄÑÏÖز¢·¢Ö¢£Û1£Ý,Ò×µ¼Ö²»Á¼Ô¤ºó£¬ÈçÎüÈëÐÔ·ÎÑס¢µç½âÖÊÎÉÂҵȸ÷ÖÖ²¢·¢Ö¢£¬ÉõÖÁËÀÍö£¬ÏÔÖøÓ°ÏìÄÔ×äÖеĿµ¸´¡£WwW.11665.COm±ÊÕßÔÚÁÙ´²¹¤×÷ÖÐ, Ó¦Ó÷縮ѨѨλעÉäÊóÉñ¾Éú³¤Òò×Ó·¨ÖÎÁƴ˲¡, È¡µÃÁ˺ܺõÄÁÆЧ, ÏÖ±¨¸æÈçÏ¡£ª¤
¡¡¡¡1 Ò»°ã×ÊÁϪ¥
¡¡¡¡Ñ¡Ôñ2008Äê1ÔÂÖÁ2009Äê12Ôµ×סÓÚÎҿƵÄÖзçºó¼ÙÐÔÇòÂé±Ô»¼Õß60Àý£¬Ëæ»ú·ÖΪÖÎÁÆ×é¡¢¶ÔÕÕ×é¸÷30Àý¡£Á½×黼ÕßµÄÄêÁä¡¢ÐԱ𡢲¡Ê·¼°²¡ÐԳ̶ȡ£¾¹ýͳ¼Æѧ´¦Àí, ²îÒìÎÞͳ¼ÆѧÒâÒå(p>0.05)£¬¾ßÓпɱÈÐÔ¡£Õï¶Ï±ê×¼£Û2£Ý£º¼ÈÍùÓÐÄÔѪ¹Ü²¡Ê·£»ÍÌÑÊÀ§ÄÑ,ÒûˮǺ¿È£»Èíëñ·´ÉäÏûʧ£¬ÑÊ·´Éä¼õÈõ£¬É༡Ô˶¯À§ÄÑ£¬ÎÞÉ༡ήËõ£»Í·²¿ct»òmri֤ʵÓÐÑÓËèÔ˶¯Éñ¾ºËÒÔÉϲ¿Î»µÄ¹£ËÀ»ò³öѪ²¡±ä¡£ÅųýÓÐÒâʶÕÏ°»¼Õߣ»ÕæÐÔÇòÂé±Ô»¼Õߣ»ÓмÙÐÔÇòÂé±ÔÖ¢×´20 dÒÔÄÚ»¼Õß¡£ª¤
¡¡¡¡2 ÖÎÁÆ·½·¨ª¤
¡¡¡¡2.1 ÖÎÁÆ×é »¼Õ߸©·ü×øλ£¬È¡·ç¸®Ñ¨£¬³£¹æÏû¶¾£¬ÒÔ5 ml×¢ÉäÆ÷½ÓÆߺÅÕëÍ·£¬³éÈ¡ÓÃ×¢ÉäÓÃË®ÈܽâµÄÊóÉñ¾Éú³¤Òò×Ó(¶÷¾¸´18¦Ìg)2 ml£¬Õë¼âÏòÑÊºí·½Ïò´ÌÈë1´ç£¬³öÏÖËáÂéÖØÕ͸У¬»Ø³éÎÞѪºóÍÆ×¢¡£1´Î/d£¬2ÖÜΪһÁƳ̡£ª¤
¡¡¡¡2.2 ¶ÔÕÕ×é ȡѨ£ºË«²à·ç³Ø£¬Ë«²àôè·çѨ£¬Á®ÈªÑ¨¼°ÅÔÁ®ÈªÑ¨£¨Á®ÈªÑ¨×óÓÒÅÔ¿ª¸÷1.5´ç£©£¬½ð½ò¡¢ÓñÒº¡£·ç³ØѨ£¬Õë¼âÑØÑÊºí·½Ïò´ÌÈë1.5¡«2´ç£»ôè·çѨ£¬ÑØÑÊºí·½ÏòÖ±´Ì2´ç£»Á®ÈªÑ¨¼°ÅÔÁ®ÈªÑ¨£¬ÏòÉà¸ù´ÌÈë1.0¡«1.5´ç£¬ÐÐÌá²åк·¨£¬ÁôÕë30 min£»µã´Ì½ð½ò¡¢ÓñÒº2~3´Î£¬ÒÔÇá΢³öѪΪ¼Ñ£¬²»ÁôÕë¡£1´Î/d£¬2ÖÜΪһÁƳ̡£ª¤
¡¡¡¡3 ÁÆЧ¹Û²ìª¤
¡¡¡¡3.1 ÁÆЧÅж¨±ê×¼ ²ÎÕÕÍÝÌïÊÏÒûË®ÊÔÑéΪÍÌÑÊÕÏ°µÄÆÀ²â±ê×¼£Û3£Ý£¬È¬Óú£ºÍÌÑÊÕÏ°Ïûʧ£¬ÒûË®ÊÔÑéÆÀ¶¨l¼¶£»ÏÔЧ£ºÍÌÑÊÕÏ°Ã÷ÏÔ¸ÄÉÆ£¬ÒûË®ÊÔÑéÆÀ¶¨2¼¶£»ºÃת£ºÑÊÕÏ°ÉÔÓиÄÉÆ£¬ÒûË®ÊÔÑéÆÀ¶¨3¼¶£»ÎÞЧ£ºÍÌÑÊÕÏ°¸ÄÉƲ»Ã÷ÏÔ£¬ÒûË®ÊÔÑéÆÀ¶¨3¼¶ÒÔÉÏ¡£ª¤
¡¡¡¡3.2 ÖÎÁƽá¹û ¾1¸öÁƳÌÖÎÁÆ£¬ÖÎÁÆ×é30Àý£¬È¬Óú13Àý£¬ÏÔЧ10Àý£¬ºÃת5Àý£¬ÎÞЧ2Àý£¬ÓúÏÔÂÊ76.67%,×ÜÓÐЧÂÊ93.33£¥£»¶ÔÕÕ×é30Àý£¬È¬Óú4Àý£¬ÏÔЧ5Àý£¬ºÃת12Àý£¬ÎÞЧ9Àý£¬ÓúÏÔÂÊ30.00%,×ÜÓÐЧÂÊ70.00%¡£Á½×é¼ä²îÒìÓÐͳ¼ÆѧÒâÒå(p<0.05)£¬ÖÎÁÆ×éµÄÁÆЧÓÅÓÚ¶ÔÕÕ×é¡£ª¤
4 ÌÖÂÛª¥
¡¡¡¡Ñ¨Î»×¢ÉäÊÇÒ»ÖÖÀûÓÃÕë´Ì×÷ÓúÍÒ©Îï×÷ÓÃÏà½áºÏÀ´ÖÎÁƼ²²¡µÄ·½·¨¡£Ëüͨ¹ýÕë´ÌµÄ»úе´Ì¼¤ºÍÒ©Àí×÷Óü¤·¢¾ÂçѨλ, ÒÔµ÷ÕûºÍ¸ÄÉƹ¦ÄÜÓ벡±ä×éÖ¯µÄ²¡Àí״̬, ʹÌåÄÚµÄÆøÔ˳©Í¨, ÓÐÕÏ°µÄ¹¦Äָܻ´Õý³£¡£²¢ÇÒÒ©ÎïÔÚѨλ´¦±»»ºÂýÎüÊÕ£¬¼ÈÔö¼Ó¶ÔѨλµÄ´Ì¼¤Ê±¼ä£¬ÓÖ¿ÉÔö¼Ó¶ÔѨλµÄ´Ì¼¤Á¿£¬ÕëÒ©²¢ÓÃÏàµÃÒæÕá£Éñ¾Éú³¤Òò×ÓÊÇÉñ¾ÏµÍ³×îÖØÒªµÄÉúÎï»îÐÔµ°°×ÎïÖÊÖ®Ò»£¬ÊÇÖÐÊ༰ÍâÖÜÉñ¾ÏµÍ³·Ö»¯¡¢·¢Óý¼°Î¬³ÖÕý³£¹¦ÄÜËù±ØÐèµÄµ°°×·Ö×Ó£¬ÄÜ´Ù½øÉñ¾ÏµÍ³ËðÉ˺óµÄÐÞ¸´¡£ÔÚÉñ¾ÏµÍ³ÓöÎïÀí¡¢»¯Ñ§µÈ¶àÖÖËðº¦Ê±£¬ÍâÔ´ÐÔÉñ¾Éú³¤Òò×Ó¿ÉÒÔ±£»¤¸Ð¾õÉñ¾ÔªºÍ½»¸ÐÉñ¾Ôª£¬¼õÇáÉ˺¦µÄ³Ì¶È£¬´Ù½øÔÙÉúÉñ¾ÏËάÉú³¤£¬ÓÐÀûÓÚÉñ¾¹¦ÄܵĻָ´¡£ª¥
¡¡¡¡·ç¸®Ñ¨´¦ÓÚÄÔºó¾±²¿Ö®Õí¹Ç´ó¿×¼°ÑÓËèÖÐÊàÌå±í´¦, Ñ¡Ôñ´ËѨÄÜʹÕë¸Ðͨ¹ýÕí¹Ç´ó¿×¡¢ÑÓËèÖÐÊàÁ¦´ïÂÄÚ, Ö±½ÓÆðµ½×îºÃµÄ¸ÄÉÆÄÔ×éÖ¯¹¦ÄܵÄ×÷Óá£ÓÐÑо¿Ö¤Êµ, Õë´Ì·ç¸®Ñ¨¶ÔÄÔѪ¹ÜÓÐÀ©ÕÅ×÷ÓÃ, ²¢¿ÉʹѪ½¬ÏËάµ°°×Ôº¬Á¿¼õÉÙ, Ѫ½¬ÏËÈÜϵͳ»îÐÔÔöÇ¿, ¶Ô²¡Ôî×éÖ¯ÓÐÁ¼ºÃµÄÖÎÁÆ×÷ÓÃ, Òà˵Ã÷´ËѨÊÇÖзçºóÒÅÖ¢Õë¾ÄÊ©ÖεÄÖ÷ҪѨλ£Û4£Ý¡£Óб¨µÀ£Û5£ÝÖ¤Ã÷¼ÓÓ÷縮Ѩ¶ÔÕë´ÌÖÎÁƼÙÐÔÇòÂé±Ô¿ÉÃ÷ÏÔÔö¼ÓÁÆЧ¡£¹ÊÑ¡Ôñ´ËѨ½øÐÐѨλעÉä¡£Ïà¹Ø±¨µÀ£Û6£Ý֤ʵ·ç¸®Ñ¨Õë´Ì·½ÏòÏò¿ÚÑʲ¿×îΪ°²È«£¬²¢ÈÏΪ½øÕë1´çΪ°²È«Éî¶È¡£ÒÔ´Ë·¨ÖÎÁÆ×äÖкóÍÌÑÊÀ§ÄÑÇÐʵÓÐЧ£¬°²È«¿É¿¿¡£ª¤
¡¡¡¡
¡¡¡¡²Î¿¼ÎÄÏת¤
¡¡¡¡£Û1£Ý ÍõÓµ¾ü.ÏÖ´úÉñ¾²¡Ñ§½øÕ¹.¿Æѧ¼¼ÊõÎÄÏ׳ö°æÉç,2004£º203.ª¤
¡¡¡¡£Û2£Ý ÍõеÂ.¸÷ÀàÄÔѪ¹Ü¼²²¡Õï¶ÏÒªµã.ÖлªÉñ¾¿ÆÔÓÖ¾,1996,29(6):379.ª¤
¡¡¡¡£Û3£Ý Áõ־˳,Áõ±£ÑÓ,ÕÅά.Õë´ÌÖÎÁÆÖзçÂýÐÔÆÚÖÐÖضÈÍÌÑÊÕÏ°ÁÙ´²Ñо¿.